Japan's Otsuka Pharmaceutical to buy Temasek-backed Visterra for $430m

Japan's Otsuka Pharmaceutical to buy Temasek-backed Visterra for $430m

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter